On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor antibody screen on the Ortho Clinical Diagnostics VISION Analyzer. This instrumentation change was necessary as Ortho Clinical Diagnostics will be discontinuing support of the existing ProVue instrumentation in the future.
We will notify you of the transition date of our other four laboratories. To read more about this change, click here: Communications
Josh Moon has been appointed Chief Operating Officer (COO) at Creative Testing Solutions (CTS), effe...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...
As winter weather continues to move through parts of the US, we would like to remind you it may be n...
The CTS 2020 Annual Laboratory Survey is on its way to your email box. We would appreciate you takin...
As the US coast prepares for Hurricane Florence to make landfall, we have received importan...